FOXG1Research

FOXG1 Research Foundation (FRF) is a non-profit organization based in Port Washington, New York. As a 501(c)(3) organization, FRF is dedicated to funding research aimed at finding a cure for FOXG1 syndrome. The organization employs four individuals and generates annual revenue of $2.5 million. FRF focuses its efforts on accelerating research for FOXG1 syndrome, a rare genetic disorder that significantly impacts brain development. Children with FOXG1 syndrome often face challenges with mobility, communication, and daily living. The organization works to support families affected by this disorder and seeks to advance scientific understanding of FOXG1. FRF's research endeavors aim to not only benefit individuals with FOXG1 syndrome but also potentially contribute to the treatment of other neurological conditions, such as autism, schizophrenia, Alzheimer's disease, and brain cancers. Founded in 2017 by parents of children with FOXG1 syndrome, FRF has rapidly gained recognition within the biotech community for its impactful work. The organization has secured significant funding and has successfully supported six major research projects, contributing to the most comprehensive study of FOXG1 to date. FRF is committed to driving progress towards clinical trials within the next three to five years. For more information about FOXG1 Research Foundation, visit their website at www.foxg1research.org.